Pivetta 2020.
Study characteristics | |||
Patient Sampling |
Purpose: diagnosis of COVID‐19 pneumonia; to explore whether the integration of lung ultrasound and clinical evaluation increases the sensitivity of the diagnosis of COVID‐19 pneumonia Design: cross‐sectional cohort study, prospective data collection Recruitment: all adult patients visiting an ED and screened positive for SARS‐CoV‐2‐associated symptoms Sample size: n = 228 (107 cases) Inclusion criteria: all adults (≥ 18 years) who screened positive for acute symptoms associated with SARS‐CoV‐2 infection at triage (= fever, dyspnoea, new or worsening cough, sore throat, diarrhoea, ageusia, anosmia and asthenia) Exclusion criteria: patients known to be infected by SARS‐CoV‐2, requiring an urgent psychiatric assessment, or already intubated at arrival, no attending physician with expertise in lung ultrasonography available |
||
Patient characteristics and setting |
Facility cases: positive RT‐PCR test for SARS‐CoV‐2, 1 test in patients with an initial positive PCR result, 2 tests in patients with an initial negative PCR result when clinical, sonographic, lab or imaging results were suggestive of COVID‐19 Facility controls: negative RT‐PCR test for SARS‐CoV‐2 and all other test results are concordant Country: Italy Dates: 01 April 2020‐20 April 2020 Symptoms and severity: ED outcome: home discharge 25.2% cases, 78.5% controls, ward admission 60.8% cases, 20.7% controls, ICU admission 7.5% cases, 0.8% controls, ED death 6.5% cases, 0% controls Demographics: age: controls median 50.3 years, cases median 62.8 years M%/F%: cases 54.1/45.9, controls 43.7/56.3 Exposure history: not specified |
||
Index tests |
|
||
Target condition and reference standard(s) |
|
||
Flow and timing | Maximum 72 h between index tests and RS | ||
Comparative | |||
Notes | Funding: none declared | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | No | ||
Did the study avoid inappropriate inclusions? | Yes | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | No | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | No | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | High | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | No | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | High risk |